Madalena Cipriano

Interested on developing strategies to improve the drug eficacy and safety evaluation process, particularly in non-clinical and non-animal models MSCA-IF fellowship: LIV-AD-ON-CHIP

Introduction of criteria on how to use non-animal methods for classification of health hazards in the GHS • To contribute to the development of draft text proposals. • Analysis of information on provided in OECD test guidance for animal methods • To collaborate to interpret the results of in vitro data in relation to the current GHS criteria using alternatives (biokinetics models).

"Development of three-dimensional umbilical cord-derived mesenchymal stem cells for differentiation into hepatocyte-like cells: a potential breakthrough in toxicological drug screening" Scientific communication: public presentations, scientific papers and patent submission Experience on working in a multidisciplinary and international collaborations

3D models for long-term hepatic in vitro toxicology applications. Strong experience with cell and tissue engineering, histology, and molecular biology, metabolism and gene expression analysis.